ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 145219 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 145219; 2) Community: the network communities that were significantly associated with the response to NSC 145219; 3) Molecule: the relationships between components within communities and NSC 145219; 4) MDR: the compounds that were significantly associated with the NSC 145219.

NSC Compound Enrichment Correlation
NSC 328784 1-Piperazinecarboselenoic acid, 4-(2-pyridinyl)-, [1-(2-pyridinyl)ethylidene]hydrazide 0.049093561024907 0.17855754
NSC 339137 PHYSALOLACTONE 0.049093561024907 0.30270899
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.049093561024907 0.15885989
NSC 39215 Null 0.049093561024907 0.20622848
NSC 45236 Null 0.049093561024907 0.30979424
NSC 601518 Null 0.049093561024907 0.25383584
NSC 603071 Aminocamptothecin 0.049093561024907 -0.028855117
NSC 606497 Camptothecin Derivative 0.049093561024907 -0.0099543437
NSC 614887 Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) 0.049093561024907 0.38872251
NSC 624657 ANTINEOPLASTIC-624657 0.049093561024907 -0.042808479
Total:183  Current:175    [First] [Prev] [Next] [Last]